SEC-MALS Compliance Suite for Development and QC
Be among the first to discover the latest advancements in SEC-MALS analysis with the newest release from Waters | Wyatt Technology. This update introduces seamless integration of MALS acquisition and analysis into enterprise-wide workflows, enhancing compliance-ready features for final development and QC. Users of DAWN™ and miniDAWN™ MALS instruments will gain expanded capabilities for in-depth size variant analysis and SEC-MALS characterization.
Join us to explore how this new release supports biotherapeutic development and QC, with case studies on monoclonal antibodies and peptides. Learn about the latest features designed to streamline characterization and help you navigate the complexities of an evolving regulatory landscape.
Presenter: Udayabagya (Bud) Halim (Sr. Marketing Analyst – Light Scattering)
Bud Halim is a Senior Marketing Analyst at Wyatt Technology, bringing a wealth of scientific expertise to the analytical instrumentation field. He earned both his B.S. and Ph.D. in Physical Chemistry from UCLA, where his passion for science began. Bud started his career in academia as an adjunct professor, teaching Biochemistry, Analytical Chemistry, and Physical Chemistry, while also contributing as an editor and author to several laboratory manuals. He later transitioned into the scientific instrumentation industry, serving in roles including applications scientist, with hands-on experience in the characterization of batteries, semiconductors, and the stability of biologics, including LNPs and viral vectors.
